Fox Chase Cancer Center Researcher Shows Biweekly Dose of TAS-102 Reduces Toxicity and Remains Effective for Treatment of Colorectal Cancer Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with treatment us...

Less can be more: A Fox Chase researcher finds that giving TAS-102 every two weeks cuts toxicity without sacrificing effectiveness in colorectal cancer treatment. #TCSC #ColorectalCancer #CancerResearch #OncologyNews #TAS102 #ChemoUpdate #CancerTreatment #FoxChase

www.foxchase.org/news/fox-cha...